
Surefire Medical study: Surefire Infusion improves liver cancer treatment
WESTMINSTER -- Surefire Medical, developer of site-specific delivery devices for the interventional oncology market, announced results from a retrospective analysis of 85 bridge-to-transplant... Read More
Friday June 9, 2017 0 comments

Surefire Medical reaches critical commercialization milestone in Germany
WESTMINSTER -- Surefire Medical, Inc. today announced the German Institute of Medical Documentation and Information (DIMDI) has issued a unique classification code (OPS) for the Surefire... Read More
Monday September 12, 2016 0 comments